Aimei Health Technology Co., Ltd (NASDAQ:AFJK – Get Free Report) was the target of a large increase in short interest in October. As of October 31st, there was short interest totalling 2,300 shares, an increase of 64.3% from the October 15th total of 1,400 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 16,700 shares, the short-interest ratio is currently 0.1 days.
Aimei Health Technology Trading Down 0.4 %
NASDAQ:AFJK opened at $10.60 on Friday. Aimei Health Technology has a 1 year low of $10.15 and a 1 year high of $10.65. The stock has a fifty day moving average price of $10.52 and a two-hundred day moving average price of $10.42.
Institutional Trading of Aimei Health Technology
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC purchased a new stake in Aimei Health Technology during the first quarter worth $190,000. Glazer Capital LLC raised its stake in shares of Aimei Health Technology by 7.2% during the 2nd quarter. Glazer Capital LLC now owns 588,774 shares of the company’s stock worth $6,094,000 after buying an additional 39,714 shares during the last quarter. Shaolin Capital Management LLC boosted its position in shares of Aimei Health Technology by 33.3% in the 2nd quarter. Shaolin Capital Management LLC now owns 400,000 shares of the company’s stock worth $4,140,000 after buying an additional 100,000 shares in the last quarter. Wolverine Asset Management LLC grew its stake in Aimei Health Technology by 8.6% in the 3rd quarter. Wolverine Asset Management LLC now owns 539,039 shares of the company’s stock valued at $5,649,000 after acquiring an additional 42,843 shares during the last quarter. Finally, Clear Street LLC purchased a new position in Aimei Health Technology during the 2nd quarter valued at about $575,000. Institutional investors and hedge funds own 45.58% of the company’s stock.
Aimei Health Technology Company Profile
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Read More
- Five stocks we like better than Aimei Health Technology
- What does consumer price index measure?
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- 3 Stocks to Consider Buying in October
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.